Ensartinib Hydrochloride Capsules (Benena) Instructions

Ensartinib Hydrochloride Capsules (Benena) is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).


File format
PDF
Published
03 November, 2023
Updated
03 November, 2023
MD5 checksum
AAD77063327E00FBEEBE9A5C97CC89E7
Download PDF

Also Manuals